| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040284064 |
| P356 | DOI | 10.1038/SJ.GT.3302471 |
| P698 | PubMed publication ID | 15750615 |
| P5875 | ResearchGate publication ID | 232799851 |
| P50 | author | Karine Breckpot | Q38326061 |
| P2093 | author name string | van der Bruggen P | |
| Corthals J | |||
| Thielemans K | |||
| Allard S | |||
| Bonehill A | |||
| Brasseur F | |||
| Dullaers M | |||
| Heirman C | |||
| Michiels A | |||
| Tuyaerts S | |||
| Van Meirvenne S | |||
| P2860 | cites work | Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells | Q57275942 |
| A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use | Q60734679 | ||
| Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability | Q71615065 | ||
| Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells | Q73035410 | ||
| Freezing of dendritic cells, generated from cryopreserved leukaphereses, does not influence their ability to induce antigen-specific immune responses or functionally react to maturation stimuli | Q73897603 | ||
| Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions | Q74179201 | ||
| mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT) | Q77314909 | ||
| The role of CD4+ T cell responses in antitumor immunity | Q77485583 | ||
| Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA | Q78410004 | ||
| Antigen presentation and T cell stimulation by dendritic cells | Q22255632 | ||
| Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization | Q24670153 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| The dendritic cell system and its role in immunogenicity | Q29619870 | ||
| Immunotherapy of cancer with dendritic-cell-based vaccines | Q32066652 | ||
| Dendritic cells. | Q33653670 | ||
| The makings of a tumor rejection antigen | Q33748013 | ||
| Gene-modified dendritic cells for use in tumor vaccines | Q33898076 | ||
| Dendritic cells in cancer immunotherapy | Q33932695 | ||
| RNA-transfected dendritic cells in cancer immunotherapy | Q34078072 | ||
| Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells | Q34141893 | ||
| Dendritic cells as vectors for therapy | Q34339199 | ||
| Dendritic cells in cancer vaccines | Q34430740 | ||
| Active immunization against cancer with dendritic cells: the near future | Q34464304 | ||
| Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity | Q34762902 | ||
| Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors | Q34787754 | ||
| Cancer immunotherapy using RNA-loaded dendritic cells. | Q35591078 | ||
| Proliferating dendritic cell progenitors in human blood | Q36363279 | ||
| Maturation, activation, and protection of dendritic cells induced by double-stranded RNA | Q36367830 | ||
| Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma | Q36375683 | ||
| The central role of CD4(+) T cells in the antitumor immune response | Q36401381 | ||
| Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes. | Q40560815 | ||
| Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells | Q40639503 | ||
| Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells | Q40701084 | ||
| Generation of large numbers of dendritic cells in a closed system using Cell Factories. | Q40709370 | ||
| Enhanced dendritic cell antigen presentation in RNA-based immunotherapy | Q40724436 | ||
| Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells | Q40814331 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. | Q41049213 | ||
| Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules. | Q41914021 | ||
| A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy | Q44245789 | ||
| Help for cytotoxic-T-cell responses is mediated by CD40 signalling | Q47982749 | ||
| A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell | Q47982760 | ||
| In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells. | Q51987584 | ||
| Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells. | Q52166693 | ||
| Human Dendritic Cells Transfected with RNA Encoding Prostate-Specific Antigen Stimulate Prostate-Specific CTL Responses In Vitro | Q56967620 | ||
| Induction of Cytotoxic T Lymphocytes With Dendritic Cells Transfected With Human Papillomavirus E6 and E7 RNA: Implications for Cervical Cancer Immunotherapy | Q56967627 | ||
| P433 | issue | 9 | |
| P921 | main subject | dendritic cell | Q506253 |
| electroporation | Q1142521 | ||
| P304 | page(s) | 772-782 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines | |
| P478 | volume | 12 |
| Q34382930 | A short pulse of IL-4 delivered by DCs electroporated with modified mRNA can both prevent and treat autoimmune diabetes in NOD mice. |
| Q41867724 | A suppressor of cytokine signaling 1 antagonist enhances antigen-presenting capacity and tumor cell antigen-specific cytotoxic T lymphocyte responses by human monocyte-derived dendritic cells |
| Q88539420 | Aligned Nanofibrillar Scaffolds for Controlled Delivery of Modified mRNA |
| Q42536013 | Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization |
| Q36240201 | Antigen-specific cellular immunotherapy of leukemia. |
| Q50471175 | CD8(+) T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC? |
| Q40170841 | CD83 expression on dendritic cells and T cells: correlation with effective immune responses |
| Q34291122 | Dendritic cell immunotherapy in uterine cancer. |
| Q37554417 | Dendritic cell-based immunotherapy in ovarian cancer |
| Q45863132 | Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells. |
| Q37467831 | Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo |
| Q34658123 | Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes |
| Q49039662 | Efficient gene transfer in CLL by mRNA electroporation. |
| Q43097170 | Electroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic Cells. |
| Q61462983 | Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA |
| Q90384384 | Establishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens |
| Q36154837 | Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs |
| Q46301219 | Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef. |
| Q42751318 | High-level antigen expression and sustained antigen presentation in dendritic cells nucleofected with wild-type viral mRNA but not DNA. |
| Q89662004 | Immune response in piglets orally immunized with recombinant Bacillus subtilis expressing the capsid protein of porcine circovirus type 2 |
| Q37591900 | In vitro transfection of bone marrow-derived dendritic cells with TATp-liposomes |
| Q40346494 | Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA. |
| Q36409054 | Intranasal delivery of vaccines against HIV. |
| Q36025111 | Isolation and generation of human dendritic cells |
| Q44800769 | Langerhans cells favor skin flora tolerance through limited presentation of bacterial antigens and induction of regulatory T cells |
| Q37008819 | Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy |
| Q39547016 | Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency |
| Q43279090 | Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase |
| Q45858586 | Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo |
| Q38116576 | Potential therapeutic applications of RNA cap analogs. |
| Q34201274 | Silencing Bruton's tyrosine kinase in alveolar neutrophils protects mice from LPS/immune complex-induced acute lung injury |
| Q61698862 | Studies on mRNA Electroporation of Immature and Mature Dendritic Cells: Effects on their Immunogenic Potential |
| Q44436557 | The combination of 4-1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV-specific T cell responses |
| Q46777207 | The impact of electrical charge on the viability and physiology of dendritic cells. |
| Q38208388 | Wilms' tumor gene 1 immunotherapy in pelvic gynecological malignancies |
| Q53092559 | mRNA Electroporation of Dendritic Cells with WT1, Survivin, and TriMix (a Mixture of caTLR4, CD40L, and CD70). |
| Q38246769 | mRNA-based dendritic cell vaccines. |
| Q38071900 | mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic. |
Search more.